New psoriasis drug study yields positive results: Dr Reddy's
According to a press release from the city-based drug-maker, the detailed safety and efficacy data from the study would be presented in future dermatology conferences.
Dr Reddy's arm sells US rights for 3 brands to Encore Dermatology
Under the terms of the agreement, Promius Pharma is eligible to receive an ...
Optimising product portfolio, focusing on key brands: GSK Pharmaceuticals
"The business has embarked on it new strategy this year, as we put ...
Sun Pharma eyes China, Japan markets
Shanghai now plans to steer the company into the specialty business (novel, innovative drugs), and towards expanding markets like China and Japan for growth, both through acquisitions and partnerships.
Dr Reddy's subsidiary sells, assigns US rights for 3 brands to Encore Dermatology
CEO G V Prasad said the announcement is in line with its renewed strategy to enable us achieve self-sustainability
Lupin enters prescription dermatology segment in Brazil
Valued at USD 28 billion, Brazil is the world's sixth largest pharmaceutical market, driven by growing public health expenditure and increasing household income.
Glenmark Q3 profit up 11% to Rs 116 crore
Consolidated revenue stood at Rs 2,555.04 crore against Rs 2,203.66 crore in the year-ago period.
Aurobindo Pharma acquires dermatology business from Sandoz in a $900 million cash deal
The acquisition will add approximately 300 products including projects in development as well as commercial and manufacturing capabilities in the US for Aurobindo.
Glenmark eyes 15% sales growth over 3-5 years
Glenmark is targeting a consolidated revenue growth of 12-15 per cent over the next 3-5 years.
Biopharma Co Vyome gets Rs 154 crore from investors
Existing investors Perceptive Advisors, Romulus Capital and Kalaari Capital also participated in this round.
Sun Pharma slips 7% after opening 2% up
In a regulatory filing, Sun Pharma said "the settlements extend to all claims brought by the Direct Purchaser Plaintiffs".
Skin ailments augment derma business in retail pharma
Increasing incidence of fungal infections, greater awareness of skin-related issues and skin care and a growing desire to look presentable are factors driving the growth, say experts.
GSK Pharma in search of buyer for non-core brands
For one of the oldest multinational drug makers in the country, the growth curve has been challenging.
Ayushman plan brilliant move; India needed it, says Rajiv Malik, President, Mylan
The Nasdaq-listed company will work with the government to expand affordable healthcare for infectious diseases like HIV and tuberculosis, US-based Mylan’s president Rajiv Malik said.
Sun Pharmaceuticals among bidders for Bayer’s dermatology brands
Private equity players KKR, Nordic Capital, Bain Capital, Blackstone and Cinven may also be looking at buying the same assets.
Copyright © 2020 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service